Foivos Sokratis
Lazaris
Investigador en el periodo 2021-2024
Publicaciones (18) Publicaciones de Foivos Sokratis Lazaris
2024
-
Development of unnatural glycopeptides based on Mucin-1 with diagnostic and therapeutic potential
6th Regular Network Meeting of the DIRNANO consortium in Salzburg
-
Non-natural MUC1 Glycopeptide Homogeneous Cancer Vaccine with Enhanced Immunogenicity and Therapeutic Activity
XXIX RSEQ Biennial Meeting in Organic Chemistry: Santa Cruz de Tenerife, June 26-28, 2024: Abstract Book
-
Non‐natural MUC1 Glycopeptide Homogeneous Cancer Vaccine with Enhanced Immunogenicity and Therapeutic Activity
Angewandte Chemie International Edition
-
Structure-Guided Approach for the Development of MUC1-Glycopeptide-Based Cancer Vaccines with Predictable Responses
JACS Au, Vol. 4, Núm. 1, pp. 150-163
2023
-
Cancer Vaccines: a distant utopia or an immediate future?
The Marie Curie Alumni Association Blog – A Researcher’s Best Fellow
-
Evaluation of the immunostimulant properties of carbon dot nanoparticles as carriers for cancer vaccines
XXXIX Reunión Bienal de Química RSEQ
-
Evaluation of the immunostimulant properties of carbon dot nanoparticles as self-adjuvating cancer vaccines
Jornadas Posdoctorales Campus Iberus Postdoctoral Days
-
Impact of structure-guided cancer nano-vaccine candidates and their respective nanoformulations in preclinical cancer models
3rd Regular Meeting of the DIRNANO consortium
-
Impact of structure-guided cancer nano-vaccine candidates and their respective nanoformulations in preclinical cancer models & biosensor development
5th Regular Meeting of the DIRNANO consortium
-
Methyl-to-Ethyl Replacement Makes the Difference: Structure-Guided Design of a New Cancer Vaccine Based on a Tn An-gen Surrogate
VI RSEQ Chemical Biology Group Meeting - ChemBio VI
-
Structure-guided design of unnatural Mucin-1 biomimetics for the development of cancer therapeutic nano-vaccines and diagnostic assays
4th Regular Meeting of the DIRNANO consortium
2022
-
Directing the immune response through designed nanomaterial. Winter School Presentation
Winter School of the DIRNANO consortium
-
Directing the immune response through designed nanomaterials. Progress Report
1st Regular Meeting of the DIRNANO consortium
-
Innovative cancer nano-vaccine based on a MUC1-like glycopeptide comprising unnatural amino acids
XXXVIII Reunión Bienal de la Real Sociedad Española de Química - RSEQ 2022 (Abstracts book)
-
Revolutionary nano-vaccine formulation exhibiting unique antigen delivery properties comprising a lipid bilayer
Summer School in Biomedical Glycoscience
2020
-
In vitro effect of hyperthermic Ag and Au Fe3O4 nanoparticles in cancer cells
Journal of B.U.ON., Vol. 25, Núm. 2, pp. 1212-1218
-
In vitro effect of hyperthermic Ag and Au Fe3O4 nanoparticles in cancer cells
Journal of B.U.ON. : official journal of the Balkan Union of Oncology, Vol. 25, Núm. 2
2019
-
Long non-coding RNA polymorphisms and prediction of response to chemotherapy based on irinotecan in patients with metastatic colorectal cancer
Cancer Biomarkers, Vol. 25, Núm. 2, pp. 213-221